Related references
Note: Only part of the references are listed.Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease
Kirupa Sathasivam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
TR-FRET-Based Duplex Immunoassay Reveals an Inverse Correlation of Soluble and Aggregated Mutant huntingtin in Huntington's Disease
Barbara Baldo et al.
CHEMISTRY & BIOLOGY (2012)
Huntingtin Aggregation Kinetics and Their Pathological Role in a Drosophila Huntington's Disease Model
Kurt R. Weiss et al.
GENETICS (2012)
Protein Misfolding Detected Early in Pathogenesis of Transgenic Mouse Model of Huntington Disease Using Amyloid Seeding Assay
Sharad Gupta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
What have we learned from gene expression profiles in Huntington's disease?
Tamara Seredenina et al.
NEUROBIOLOGY OF DISEASE (2012)
Huntington's disease: from molecular pathogenesis to clinical treatment
Christopher A. Ross et al.
LANCET NEUROLOGY (2011)
A Two-Step Path to Inclusion Formation of Huntingtin Peptides Revealed by Number and Brightness Analysis
Giulia Ossato et al.
BIOPHYSICAL JOURNAL (2010)
Proteolysis of Mutant Huntingtin Produces an Exon 1 Fragment That Accumulates as an Aggregated Protein in Neuronal Nuclei in Huntington Disease
Christian Landles et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Live axonal transport disruption by mutant huntingtin fragments in Drosophila motor neuron axons
C. Sinadinos et al.
NEUROBIOLOGY OF DISEASE (2009)
N-terminal proteolysis of full-length mutant huntingtin in an inducible PC12 cell model of Huntington's disease
Tamara Ratovitski et al.
CELL CYCLE (2007)
Drug targeting of dysregulated transcription in Huntington's disease
Aleksey G. Kazantsev et al.
PROGRESS IN NEUROBIOLOGY (2007)
Global changes to the ubiquitin system in Huntington's disease
Eric J. Bennett et al.
NATURE (2007)
Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage
Alexandre Kuhn et al.
HUMAN MOLECULAR GENETICS (2007)
Characterization of huntingtin pathologic fragments in human Huntington disease, transgenic mice, and cell models
Gabriele Schilling et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2007)
An optimized transgenesis system for Drosophila using germ-line-specific φC31 integrases
Johannes Bischof et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A guided tour into subcellular colocalization analysis in light microscopy
S. Bolte et al.
JOURNAL OF MICROSCOPY (2006)
Normal-repeat-length polyglutamine peptides accelerate aggregation nucleation and cytotoxicity of expanded polyglutamine proteins
Natalia Slepko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin
Rona K. Graham et al.
CELL (2006)
Identification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila
N Agrawal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
SUMO modification of Huntingtin and Huntington's disease pathology
JS Steffan et al.
SCIENCE (2004)
Inhibition of calpain cleavage of huntingtin reduces toxicity - Accumulation of calpain/caspase fragments in the nucleus
J Gafni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Can flies help humans treat neurodegenerative diseases?
JL Marsh et al.
BIOESSAYS (2004)
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
R Kayed et al.
SCIENCE (2003)
Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders
I Sánchez et al.
NATURE (2003)
The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans
JF Morley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Proteases acting on mutant Huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions
A Lunkes et al.
MOLECULAR CELL (2002)
Altered transcription in yeast expressing expanded polyglutamine
RE Hughes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis
YJ Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila
JS Steffan et al.
NATURE (2001)
Structure and function of type II restriction endonucleases
A Pingoud et al.
NUCLEIC ACIDS RESEARCH (2001)
Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells
CL Wellington et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans
SH Satyal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Caspases and neurodegeneration: on the cutting edge of new therapeutic approaches
CL Wellington et al.
CLINICAL GENETICS (2000)
Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila
JL Marsh et al.
HUMAN MOLECULAR GENETICS (2000)
Share Paper
